Literature DB >> 5102638

Physostigmine treatment of anticholinergic-drug depression in postoperative patients.

L T Greene.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5102638

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  11 in total

1.  Experiences with physostigmine in the reversal of adverse post-anaesthetic effects.

Authors:  J Brebner; L Hadley
Journal:  Can Anaesth Soc J       Date:  1976-11

2.  Letters to the editor.

Authors:  R S Garrison
Journal:  Anesth Prog       Date:  1978-03

Review 3.  Adverse Effects of Physostigmine.

Authors:  Ann M Arens; Tom Kearney
Journal:  J Med Toxicol       Date:  2019-02-11

4.  Postoperative delirium secondary to atropine premedication.

Authors:  K Hammon; B K DeMartino
Journal:  Anesth Prog       Date:  1985 May-Jun

5.  A randomized evaluation of the reversal of ketamine by physostigmine.

Authors:  J C Drummond; J Brebner; S Galloon; P S Young
Journal:  Can Anaesth Soc J       Date:  1979-07

Review 6.  Diagnosing and managing delirium in the elderly.

Authors:  D K Conn; S Lieff
Journal:  Can Fam Physician       Date:  2001-01       Impact factor: 3.275

7.  Cholinergic effects on fear conditioning II: nicotinic and muscarinic modulations of atropine-induced disruption of the degraded contingency effect.

Authors:  Sebastien Carnicella; Laure Pain; Philippe Oberling
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

8.  Physostigmine as an adjuvent to neuroleptanaesthesia in neurosurgical procedures.

Authors:  D E Thompson
Journal:  Can Anaesth Soc J       Date:  1976-11

Review 9.  Pharmacological management of anticholinergic delirium - theory, evidence and practice.

Authors:  Andrew H Dawson; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2015-12-29       Impact factor: 4.335

10.  Prevention and Management of Delirium in the Intensive Care Unit.

Authors:  Matthew F Mart; Shawniqua Williams Roberson; Barbara Salas; Pratik P Pandharipande; E Wesley Ely
Journal:  Semin Respir Crit Care Med       Date:  2020-08-03       Impact factor: 3.119
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.